Protein Kinase Modulators

Anti-NADK NAD kinase, 100ul UN 1687 6.1 PG2

Anti-NADK NAD kinase, 25ul UN 1687 6.1 PG2

A phthalazinone derived compound that directly binds to the 22-kDa amino-terminal region of apolipoprotein E4 (ApoE4) and blocks its intramolecular domain interactions in neuronal cells (IC 50 = 116 nM) thereby reversing the detrimental effects of

A cell-permeable, pyrimidine derivative that acts as an ATP-competitive CDK Inhibitor (K i = 2.5 &#181M for CDK1, and K i = 1.

A cell-permeable phenylimidazopyridinyl-methoxy coumarin compound that inhibits caspase-3 and caspase-6 activities (IC 50 = 35 and 38 &#181M, respectively) by targeting both the large and small subunit active sites. Kinetic studies with 1541 and

A cell-permeable, of 8-Hydroxy 1541 (Cat. No.

CONTROLLER PANEL MOUNT MODCON75

Cell Line Origin Mouse NS1 x Mouse BALB/c spleen Cell Line Description The antibody is directed against oxysterol binding protein. Immunogen Recombinant peptide 8 of hamster liver oxysterol binding protein coupled to KLH Application Studying the

An inactive control for I&#954B Kinase Inhibitor Peptide (Cat. No.

A cell-permeable tetrabrominated cinnamic acid compound that acts as a potent and ATP-competitive inhibitor of Casein Kinase II (IC 50 = 110 nM, K i = 77 nM) with greater selectivity than TBB ( >Cat. No.

A cell-permeable pyrazolopyrimidine compound that acts as a potent and ATP-competitive mTOR inhibitor (IC 50 = 5 nM with S6K as the substrate and 100 &#181M ATP) with much reduced activity against PI 3-K&#945 or PI 3-K&#947 (IC 50 = 1.89 and 7.

A cell-permeable phenylamino-dibenzosuberone-diol with a rigid molecular structure specifically designed to target hydrophobic region I in p38&#945 &amp p38&#946, but not in other kinases with bulky entrance-blocking gatekeeper residues. Shown